Cancer and Tobacco Awareness Program at IOCL on WCD 2024

On February 2, 2023, a Cancer and Tobacco Awareness Program was conducted for the workers of Indian Oil Corporation Limited (IOCL), Mathura, on the occasion of World Cancer Day 2024. The program was organized by MAX Institute of Cancer Care, Vaishali, in association with IOCL, Mathura.

The chief speaker of the program was Dr. Pawan Gupta, M.Ch., Sr. Director, MAX Institute of Cancer Care, Vaishali, who is a renowned oncologist and an expert in tobacco cessation. He was honored by Mr. Vikram Phuleriya, DGM Marketing, IOCL, Mathura, who presented him with a memento and thanked him for his valuable service. The program was coordinated by Mr. Sonu Patel, Safety Officer, IOCL, Mathura, and doctors Dr. Pronita Banerjee and Dr. Pradyuman Kaushik. MAX was represented by Mr. Sachin Bhatia and Mr. Lalit Kumar.

The program was attended by 45 workers of IOCL, Mathura, who actively participated in the interactive session. Dr. Pawan Gupta talked about cancer and its prevention, emphasizing tobacco as the main cause. He showed a video presentation that illustrated how harmful tobacco is to the health and well-being of the users and their families. He informed the workers that tobacco is responsible for more than 50% of the 16 types of cancers that are known to be caused by it. He also explained the various signs and symptoms of oral cancer, such as white patches, red patches, nodules, ulcers, or pigmentation in the oral cavity. He urged the workers to do a self-oral examination and look for any abnormality or lesion in their mouth. He demonstrated a simple four-finger mouth-opening test and found that seven of the workers had a mouth opening of fewer than two fingers, which is alarming and needs intervention. He warned the workers that oral premalignant lesions, if not treated at the right time, have a 70% chance of becoming cancerous.

Knowing this it created a fear in the minds of the workers taking tobacco!

Dr. Gupta also talked about the advancements in medical science and the availability of effective treatment for tobacco cessation. He said that specific medicines are given to each individual, based on their assessment and monitoring, and the treatment usually lasts for three to six months. He added that some people may need two or three attempts before they can quit tobacco completely. He encouraged the workers to seek professional help and support to quit tobacco and improve their quality of life.

During the interaction, Dr Gupta asked the following questions to the participants –

1.      How many of them were taking tobacco of any form-

a.      37 responded by raising their hands

2.      How many have never taken tobacco in their lifetime

a.      7 never took tobacco any time in life

3.      How many do yoga or exercise

a.      No one did yoga or exercise or meditation

4.      Amongst the tobacco users, How many knew that tobacco is bad

a.      100% new tobacco is bad

5.      How many have attempted to quit tobacco any time in life

a.      32 of 37 have tried but failed

6.      How many wished to quit tobacco

a.      46 of 47 wished to quit tobacco

7.      After explaining that it is possible to quit tobacco through medical means specific medications are available and it is done with scientific protocol-based methodology all of the workers were eager to quit tobacco and wished such a facility was provided to them.

8.      How many are ready to pay for their treatment but want to quit – 100% were ready for the same.

9.      7 of the workers had decreased mouth opening and needed immediate intervention.

Tobacco users were suggested to do a self-oral examination and look for Chota Daana in the oral cavity which can be in the form of a white patch, red patch, nodule, ulcer, or just pigmentation. A simple 4 finger mouth opening test was done and 7 of the workers had a mouth opening of less than 2, which is alarming and needs intervention. Oral premalignant lesions if not taken care of at the right time 70% of them are likely to become cancers!!

A need was felt that oral screening and tobacco cessation facilities be available for the workers and employees on the premises.

The program was a success and received positive feedback from the workers, who expressed their gratitude and appreciation for the opportunity to learn and benefit from such a useful and informative initiative.

The program was a part of IOCL’s and MAX’s ongoing efforts to promote and enhance the health and safety of the workers and their families and to contribute to the global fight against cancer. IOCL and MAX hope to continue and expand their programs on cancer and tobacco awareness and prevention in the future and to inspire and empower the workers and their families to lead healthy and happy lives.

Dr. Pawan Gupta MS. (Gen Surgery), M.Ch. (Surgical Oncology), FAIS, FSOG, CTCS

Sr. Director, Surgical Oncology, MAX Institute of Cancer Care, EZ-   Delhi NCR

           Founder Director – ICanCaRe, ICanCaRe Academy

Adopting Tobacco Cessation in Real World Clinical Practice

The firstever full symposium focussing on tobacco Cessation was held at the just concluded 23rd Foundation for Head and Neck Oncology National Conference held at Daman from 22nd to 24th December. Thanks to the organizing committee for including this important topic in FHNO – Dr. Rajesh Kantharia, Dr. Prathamesh Pai, Dr. P. Arun, Dr. Dushyant Mandlik

The symposium was Chaired by Dr. Naresh Sharma,  HOD – Oro-maxillofacial Surgery, BHU, Varanasi, and conducted by Dr Pawan Gupta Sr. Director Surgical Oncology, MAX Institute of Cancer Care, Vaishali and founder of ICanCaRe.

Dr. Ajay Vidyarthi, HOD Surgical Oncology, Bhagwan Mahavir Cancer Sansthan, Patna spoke on “Integrating Tobacco Cessation to Improve Treatment Outcome in Clinical Practice”, highlighting the evidence for Tobacco Cessation in oncology practice.

A QUIZ – EVOLVE and ENGAGE Tobacco Cessation was conducted by the quiz MASTER – Dr. Suman Kharkwal (Delhi), HOD, Surgical oncology, ESI Hospital Delhi, and Coordinator – Dr. Bhavya Mishra fellow at MAX Hospital Delhi. The winners of the quiz were selected for the Scholarship for Certified Tobacco Cessation Specialist Course accredited by Gujarat University.

This was followed by a panel discussion. Prathamesh Pai, Dr. P. Arun, Dr. Dushyant Mandlik

The symposium was Chaired by Dr. Naresh Sharma,  HOD – Oro-maxillofacial Surgery, BHU, Varanasi, and conducted by Dr Pawan Gupta Sr. Director Surgical Oncology, MAX Institute of Cancer Care, Vaishali and founder of ICanCaRe.

Dr. Ajay Vidyarthi, HOD Surgical Oncology, Bhagwan Mahavir Cancer Sansthan, Patna spoke on “Integrating Tobacco Cessation to Improve Treatment Outcome in Clinical Practice”, highlighting the evidence for Tobacco Cessation in oncology practice.

A QUIZ – EVOLVE and ENGAGE Tobacco Cessation was conducted by the quiz MASTER – Dr. Suman Kharkwal (Delhi), HOD, Surgical oncology, ESI Hospital Delhi, and Coordinator – Dr. Bhavya Mishra fellow at MAX Hospital Delhi. The winners of the quiz were selected for the Scholarship for Certified Tobacco Cessation Specialist Course accredited by Gujarat University.

This was followed by a panel discussion “ADOPTING TOBACCO CESSATION in Real World Clinical  Practice”. The panel was moderated by Dr. Pawan Gupta and panelists were –

·      Dr. Ajay Vidyarthi (Patna)

·       Susan Samson Anant Mrs. Susan Samson, NGO (Vadodara)President, Faith Foundation, Vadodara

·       Dr Snehal Shah HN (Mumbai)

·       Dr. Suman Kharkwal (Delhi)

·       Dr AMEYA BIHANI HN Sr. Consultant, HCG Hospital (Indore)

·       Dr. Akhilesh Kumar Singh, Asso Prof, OMFS, BHU (Varanasi)

·       Dr. Uma Shankar Pal, HOD, OMFS, KGMU,  (Lucknow)

·       ghatdeep kaur Dr. Ghatdeep Kaur, Fellow, FHNO, MAX Hospital (Delhi)

TrisCaRe was given away to all the panelists and enthusiastic participants in the audience.

The symposium ended on a high note with everyone agreeing that Tobacco Cessation should be an integral part of the head and neck oncology practice and an integral part of the training during fellowship or specialization.

#icancareacademy #icancare #icancareepharmacy #icancarescholarships #CTCS #Tobaccocessation #FHNO #Bhavyamishra #IAPSM #sumankharkwal #pawangupta #ahmadzahoor #rajeshkantharia

Smokers with diabetes and hypertension at higher risk of Cardiovascular events

“Smokers with diabetes and hypertension at higher risk of Cardiovascular events”. – ICanCaRe

Introduction:

I continuation of our previous blog article on the risk of smoking and diabetes type 2, a recent article on a link of CVD with diabetes, highlights the need for a comprehensive smoking cessation program for such patients.

In the complex landscape of managing type 2 diabetes, the link between blood pressure levels and cardiovascular disease (CVD) mortality has emerged as a critical focal point. A recent study published in the Journal of the American Heart Association delves into the intricate relationship between systolic and diastolic blood pressure (BP) levels and their impact on mortality in patients with type 2 diabetes. The findings, drawn from a multi-institutional diabetes registry in Singapore, underscore the urgency for comprehensive interventions like ICanCaRe to address the cardiovascular risks associated with type 2 diabetes.

Unraveling the Study’s Objectives:

Led by Loraine Liping Seng and her colleagues, the study aimed to unravel the correlation between systolic and diastolic BP levels and the risk of CVD mortality in patients with type 2 diabetes. Additionally, the study explored associations with all-cause mortality, the composite outcome of all-cause mortality and CVD hospitalization, and the composite outcome of CVD mortality and hospitalization due to specific cardiovascular events such as myocardial infarction (MI), heart failure (HF), stroke, bypass surgery (CABG), and percutaneous coronary intervention (PCI).

The Singaporean Perspective:

Utilizing data from a multi-ethnic Asian patient pool – Chinese, Malay, and Indian – the study delved into a rich repository of information encompassing primary care to hospital-based care. The comprehensive analysis included 83,721 patients with type 2 diabetes over a span of seven years. Notably, almost 80% of the participants were on antihypertensive treatment, highlighting the prevalence of the condition in this population.

Key Findings and Implications:

The study’s primary outcome revealed a notable association between clinic systolic BP of 130 mm Hg or higher and/or diastolic BP of 90 mm Hg or greater with an increased risk of CVD mortality in patients with type 2 diabetes. Intriguingly, adverse cardiovascular outcomes were also paradoxically linked to diastolic blood pressure levels below 70 mm Hg. While the authors acknowledge the potential influence of reverse causality, the study emphasizes the importance of maintaining systolic BP below 130 mm Hg and diastolic BP below 90 mm Hg in individuals with type 2 diabetes.

ICanCaRe: A Holistic Approach to Cardiovascular and diabetic Health:

In light of these findings, the ICanCaRe Tobacco Intervention program takes center stage as a holistic approach to address the multifaceted challenges posed by type 2 diabetes. Recognizing the intricate interplay between cardiovascular health, diabetes, and other lifestyle factors, ICanCaRe empowers individuals to make informed choices and adopt a comprehensive approach to well-being. The ICanCaRe program is designed to offer personalized support to individuals seeking to quit Tobacco. Understanding that each journey is unique, the program tailors its strategies to meet each participant’s specific needs and challenges. (www.app.icancare.in). Medical assistance in a protocol-based approach is provided by Certified Tobacco Cessation Specialists. This multi-faceted ABCD approach for tobacco cessation ensures that individuals have access to all necessary resources to 100% quit smoking or Chewing tobacco.

Conclusion:

As the nexus between type 2 diabetes, blood pressure levels, and cardiovascular risks becomes clearer, interventions like ICanCaRe gain significance in the realm of patient care. By integrating the latest research findings into its framework, ICanCaRe supports tobacco cessation, guiding individuals through the complexities of managing diabetes and promoting cardiovascular health. In a world where data illuminates the path to better outcomes, the ICanCaRe program becomes an invaluable tool in the fight against the complications of type 2 diabetes with increased risk with smoking, offering a lifeline to those seeking a healthier, more empowered future.

Reference:

  1. Loraine Liping Seng, et al. Real-world systolic and diastolic blood pressure levels and cardiovascular mortality in patients with type 2 diabetes-results from a large registry cohort in Asia. J Am Heart Assoc. 2023 Nov 28:e030772. doi: 10.1161/JAHA.123.030772.
  2. World Health Organization, International Diabetes Federation, and the University of Newcastle. “Policy Brief on Smoking and Type 2 Diabetes.” This brief offers a comprehensive overview of the research linking smoking cessation to a reduced risk of type 2 diabetes.
  3. ICanCaRe. “Tobacco Cessation Program Overview.” www.icancare.in
  4. American Diabetes Association. “The Impact of Smoking on Diabetes and Diabetes Management.” This article discusses the implications of smoking on diabetes management and the benefits of cessation.
  5. National Institute of Diabetes and Digestive and Kidney Diseases. “Smoking and Diabetes.” This resource offers a deeper understanding of how smoking affects diabetes risk and control.
  6. ICanCaRe. (2021). ABCD of Tobacco Cessation. https://www.icancare.org/abcd.html

#icancare #diabetesandSmoking #smoking #quittobacco #icancareapp #CVDandsmoking